Humasis Co. Ltd.

Research Humasis Co. Ltd. (205470.KQ) on Bullrun: market cap KRW 60.39B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker205470.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryMedical Devices
CurrencyKRW
Market capKRW 60.39B
Financial periodQ2 2026
RevenueKRW 7.74B
Net income-KRW 11.22B
Free cash flowKRW 1.77B
Gross margin14.4%

Valuation Snapshot

latest market cap is KRW 60.39B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 60.39B	n/a	n/a	n/a

About Humasis Co. Ltd.

Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women's health.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

JPI Healthcare Co.,Ltd. (0010V0.KQ) Shinhung Co., Ltd (004080.KS) Osang Healthcare Co.,Ltd (036220.KQ) HansBiomed Corporation (042520.KQ) JVM Co., Ltd. (054950.KQ) CG MedTech Co.,Ltd. (056090.KQ) Huvitz Co., Ltd. (065510.KQ) Vieworks Co., Ltd. (100120.KQ) Corentec Co., Ltd. (104540.KQ) SD Biosensor, Inc. (137310.KS) Hironic Co., Ltd. (149980.KQ) L&K Biomed Ltd. (156100.KQ)

Frequently asked questions

What is Humasis Co. Ltd.'s market cap?

Humasis Co. Ltd.'s market capitalization is KRW 60.39B.